Celularity is a biotechnology company that specializes in leveraging biologically active cell populations within the postpartum human placenta. Founded on the pioneering work of Robert Hariri, MD, PhD, in human placenta-derived cellular therapeutics and biomaterials, Celularity is uniquely positioned to harness the potential of most biocreative event on earth: human birth. [Read more…]
Stem Cell Injection For Knee Pain, Arthritis, Tendonitis, And Joints
Stem cell injections are an intriguing treatment option for different conditions such as knee pain, osteoarthritis, and tendonitis. While the science and technology behind this approach are early-stage, they are advancing at a rapid rate. Learn how it works and how stem cell injections may be able to help manage joint pain.
Stem Cell Injections for Joint Pain
In This Article:
Multipotent Stem Cell Benefits and Their Emerging Uses in Medicine
Multipotent stem cell research has come into the mainstream, as regenerative medicine exits its infancy and begins to take hold in major healthcare markets worldwide. The possibilities inherent in multipotent stem cells – those capable of turning into a wide variety of different bodily cells – make it one of the most exciting developments today. [Read more…]
Caribou Biosciences Granted FDA RMAT and Fast Track Designations for CB-010, an Allogeneic Anti-CD19 CAR-T Cell Therapy
RMAT and Fast Track designations follow CB-010’s durable complete responses at dose level 1 in the ANTLER Phase 1 trial
CB-010 is the 1st allogeneic CAR-T cell therapy in the clinic with a PD-1 knockout
CAR-T Market: Current State, Future Directions, and Trends
The global CAR-T market has grown exponentially since the first CAR-T approval reached the market in 2017. Over the past four years, a growing pipeline of CAR-T clinical trials have been accumulating, leading to six global approvals and an explosion of CAR-T market competitors worldwide. [Read more…]
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 47
- Next Page »